Latest KB001-A Stories
KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients
Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 6, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.
Word of the Day
- A volcanic mudflow.
The word 'lahar' comes from Javanese.